TABLE 4.
Adjusted mean values of total homocysteine (tHcy) by quintile (Q) of energy-adjusted choline-containing compounds1
Nutrient intake |
Percentage change (Q1—Q5) | ||||||
---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | P for trend2 | ||
% | |||||||
Water-soluble | |||||||
Choline from glycerophosphocholine3 | |||||||
Median intake (mg/d) | 34.3 | 43.6 | 51.1 | 61.7 | 80.0 | ||
Range | < 39.3 | 39.4−47.3 | 47.4−56.3 | 56.3−68.9 | >68.9 | ||
Age-adjusted tHcy | 11.6 ± 0.34 | 11.1 ± 0.3 | 10.5 ± 0.25 | 10.4 ± 0.35 | 9.5 ± 0.25 | −18 | < 0.001 |
Model 16 | 11.6 ± 0.3 | 11.0 ± 0.3 | 10.5 ± 0.25 | 10.3 ± 0.35 | 9.6 ± 0.25 | −17 | < 0.001 |
Model 27 | 11.1 ± 0.3 | 10.8 ± 0.3 | 10.5 ± 0.2 | 10.6 ± 0.3 | 10.0 ± 0.25 | −10 | < 0.01 |
Choline from phosphocholine8 | |||||||
Median intake (mg/d) | 10.2 | 12.5 | 14.3 | 16.6 | 20.3 | ||
Range | < 11.5 | 11.5−13.4 | 13.4−15.4 | 15.4−18.0 | > 18.0 | ||
Age-adjusted tHcy | 11.6 ± 0.3 | 11.2 ± 0.3 | 10.9 ± 0.3 | 9.9 ± 0.25 | 9.4 ± 0.25 | −19 | < 0.001 |
Model 16 | 11.5 ± 0.3 | 11.2 ± 0.3 | 10.9 ± 0.3 | 9.9 ± 0.25 | 9.5 ± 0.25 | −17 | < 0.001 |
Model 27 | 10.9 ± 0.3 | 11.0 ± 0.3 | 11.0 ± 0.3 | 10.1 ± 0.25 | 10.0 ± 0.25 | −8 | 0.001 |
Free choline9 | |||||||
Median intake (mg/d) | 58.5 | 67.5 | 73.8 | 80.8 | 92.8 | ||
Range | < 63.6 | 63.6−71.0 | 71.0−77.4 | 77.4−85.8 | >85.9 | ||
Age-adjusted tHcy | 11.0 ± 0.2 | 10.8 ± 0.2 | 10.7 ± 0.3 | 10.3 ± 0.25 | 10.2 ± 0.25 | −7 | 0.009 |
Model 16 | 11.3 ± 0.3 | 10.9 ± 0.2 | 10.6 ± 0.3 | 10.2 ± 0.35 | 10.0 ± 0.35 | −12 | < 0.001 |
Model 27 | 10.7 ± 0.3 | 10.6 ± 0.2 | 10.8 ± 0.3 | 10.4 ± 0.2 | 10.5 ± 0.3 | −2 | 0.47 |
Lipid-soluble | |||||||
Choline from phosphatidylcholine10 | |||||||
Median intake (mg/d) | 120 | 140 | 157 | 175 | 207 | ||
Range | < 131 | 131−148 | 148−164 | 164−187 | > 187 | ||
Age-adjusted tHcy | 10.7 ± 0.3 | 10.7 ± 0.2 | 10.4 ± 0.3 | 10.4 ± 0.2 | 10.8 ± 0.3 | 1 | 0.99 |
Model 16 | 10.3 ± 0.3 | 10.6 ± 0.2 | 10.5 ± 0.3 | 10.7 ± 0.2 | 11.0 ± 0.3 | 7 | 0.10 |
Model 27 | 10.5 ± 0.3 | 10.5 ± 0.2 | 10.5 ± 0.3 | 10.5 ± 0.2 | 11.0 ± 0.3 | 5 | 0.17 |
Choline from sphingomyelin11 | |||||||
Median intake (mg/d) | 13.4 | 16.1 | 18.2 | 20.4 | 23.7 | ||
Range | < 14.9 | 14.9−17.2 | 17.2−19.3 | 19.3−21.9 | >21.9 | ||
Age-adjusted tHcy | 10.8 ± 0.3 | 10.8 ± 0.3 | 10.5 ± 0.3 | 10.5 ± 0.2 | 10.5 ± 0.3 | −3 | 0.32 |
Model 16 | 9.9 ± 0.3 | 10.4 ± 0.3 | 10.4 ± 0.3 | 11.0 ± 0.35 | 11.3 ± 0.45 | 14 | 0.02 |
Model 27 | 10.5 ± 0.4 | 10.6 ± 0.3 | 10.3 ± 0.3 | 10.7 ± 0.3 | 11.0 ± 0.3 | 5 | 0.39 |
n = 295 in each quintile unless stated otherwise.
Linear regression coefficient for continuous variable was based on the median value from each quintile.
n = 296 in Q3 and Q4.
x̄ ± SEM (all such values).
Significantly different from Q1 according to linear regression models, P < 0.05 (Wald test).
Model 1 was adjusted for age, smoking status, menopausal status, laboratory batch, coffee, total calories, and intakes of methionine and alcohol.
Model 2 was adjusted as model 1 plus for intakes of folate and riboflavin.
n = 297 in Q1, 293 in Q2, and 296 in Q3 and Q4.
n = 296 in Q1, Q3, and Q4 and 294 in Q2.
n = 296 in Q2 and Q5.
n = 297 in Q3 and Q5 and 293 in Q4.